Breast Cancer
Conference Coverage
Lumpectomy plus reconstruction outperforms mastectomy plus reconstruction
LAS VEGAS – Lumpectomy combined with plastic surgery had nearly the same cost and complication rate as lumpectomy alone, and was cheaper and safer...
Conference Coverage
Study underscores aggressive approach to inflammatory breast cancer
A study of inflammatory breast cancer between 2007 and 2015 showed the best results for patients treated with aggressive trimodality therapy.
Conference Coverage
Multimodal breast cancer treatment linked with greater risk of lymphedema
Chemotherapy, radiation, and higher BMI are strongly associated with increased risk of lymphedema in breast cancer patients who have undergone...
Conference Coverage
Risk of recurrence outweighs risk of contralateral breast cancer for DCIS patients
LAS VEGAS – Double mastectomies are not as necessary as many women with DCIS believe them to be.
Feature
Practice-changing endocrine trials shed light on breast cancer treatment, management
At the 2016 San Antonio Breast Cancer Symposium, investigators presented findings on PFS benefits of adding an mTOR inhibitor to anti-hormonal...
Case Reports
Single-, low-dose cyclophosphamide-associated severe hyponatremia with seizures in a patient with breast cancer
From the Journals
Palbociclib/fulvestrant works in Asians with HR+/HER2– breast cancer too
In the PALOMA-3 trial, palbociclib plus fulvestrant outperformed fulvestrant with placebo.
From the Journals
Only some genes count in breast cancer panels
Germline variants in PALB2 were associated with a more than sevenfold greater risk for breast cancer.
Conference Coverage
NET can benefit breast cancer patients with delayed surgery
For breast cancer patients whose surgery is delayed, a course of neoadjuvant therapy may be beneficial, but the effectiveness depends on the...
Conference Coverage
Atezolizumab improved survival in triple-negative breast cancer
In a phase I trial, the immunotherapy agent atezolizumab improved survival in triple-negative breast cancer.
Conference Coverage
BRCA2 mutations linked to greater risk for pancreatic cancer
MIAMI BEACH – A higher incidence of pancreatic abnormalities on imaging among BRCA2 mutation carriers may provide a potential screening target.